Nitric Acid

Nitric Acid

SCHEMBL9874582

O=[N+]([O-])O.OC1CCCCC1O

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ERG11

The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
GSR P00390 7/20 0.54
CA5A P35218 1/20 0.47
CA5B Q9Y2D0 1/20 0.47
CA2 P00918 4/20 0.39
CA1 P00915 3/20 0.39
CA4 P22748 3/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
SLC18A3 Q16572 4/20 0.36
TSHR P16473 2/20 0.35
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitric Acid SCHEMBL9803591 1.00 GSR (0.54) GSRCA5ACA5BCA2CA1
Nitric Acid SCHEMBL9803296 0.88 CA5A (0.53) GSRCA5ACA5BCA2
Cyclohexanol SCHEMBL9019597 0.80 TSHR (0.56) GSRCA5ACA5BCA2MEN1
Cyclohexanol SCHEMBL9019499 0.80 TSHR (0.56) GSRCA5ACA5BCA2MEN1
Nitric Acid SCHEMBL11228157 0.79 ALDH1A1 (0.50) GSRCA5ACA5BCA2MEN1
SCHEMBL812021 0.77
SCHEMBL379845 0.77
SCHEMBL33549 0.77
SCHEMBL9386322 0.77
SCHEMBL2369775 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5049694-A Cardiovascular disorders CEDONA PHARMACEUTICALS B.V. (NL) 1991-09-17 US disclosed
EP-0359335-A2 Pharmaceutical composition having relaxing activity which contains a nitrate ester as active substance CEDONA PHARMACEUTICALS B.V. (NL) 1990-03-21 EP disclosed